These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 9407458
1. Mechanism of decreased albuminuria caused by angiotensin converting enzyme inhibitor in early diabetic nephropathy. Imanishi M, Yoshioka K, Okumura M, Konishi Y, Tanaka S, Fujii S, Kimura G. Kidney Int Suppl; 1997 Dec; 63():S198-200. PubMed ID: 9407458 [Abstract] [Full Text] [Related]
3. [Urinary albumin excretion in non-insulin-dependent diabetic patients. Effects of an angiotensin-converting enzyme inhibitor]. Durruty P, Tapia JC, Ugarte C, Pérez E, Krause P, Soto N, García de los Ríos M. Rev Med Chil; 1996 Sep; 124(9):1036-44. PubMed ID: 9197016 [Abstract] [Full Text] [Related]
5. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy. Salako BL, Finomo FO, Kadiri S, Arije A, Olatosin AO. Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931 [Abstract] [Full Text] [Related]
6. Effects of captopril on urinary excretion of albumin and prostaglandins in patients with diabetic nephropathy. Tajiri Y, Umeda F, Inoguchi T, Kunisaki M, Nawata H, Ninomiya H, Asano T. Diabetes Res; 1990 Mar; 13(3):145-50. PubMed ID: 2091882 [Abstract] [Full Text] [Related]
7. Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy. Sato A, Tabata M, Hayashi K, Saruta T. Clin Exp Nephrol; 2003 Sep; 7(3):215-20. PubMed ID: 14586718 [Abstract] [Full Text] [Related]
9. Effects on urinary albumin excretion and renal function changes by delapril and manidipine in normotensive type 2 diabetic patients with microalbuminuria. Deerochanawong C, Kornthong P, Phongwiratchai S, Serirat S. J Med Assoc Thai; 2001 Feb; 84(2):234-41. PubMed ID: 11336083 [Abstract] [Full Text] [Related]
12. The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency. Tong PC, Ko GT, Chan WB, Ma RC, So WY, Lo MK, Lee KF, Ozaki R, Chow CC, Cockram CS, Chan JC. Diabetes Obes Metab; 2006 May; 8(3):342-7. PubMed ID: 16634995 [Abstract] [Full Text] [Related]
13. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes. Chuahirun T, Khanna A, Kimball K, Wesson DE. Am J Kidney Dis; 2003 Jan; 41(1):13-21. PubMed ID: 12500217 [Abstract] [Full Text] [Related]
14. ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria. Poulsen PL. J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):17-26. PubMed ID: 12692749 [Abstract] [Full Text] [Related]
15. Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone. Schjoedt KJ, Jacobsen P, Rossing K, Boomsma F, Parving HH. Horm Metab Res; 2005 Apr; 37 Suppl 1():4-8. PubMed ID: 15918104 [Abstract] [Full Text] [Related]